Ionis Pharmaceuticals’ RNA-targeted drug Waylivra has been conditionally approved in Europe for the devastating ultra-rare disease Familial Chylomicronemia Syndrome (FCS).

The U.S. Food and Drug Administration said on Friday it had eliminated risk evaluation and mitigation strategies (REMS), a ...

On June 16, 2025, the U.S. Environmental Protection Agency (EPA) filed a motion with the U.S. Court of Appeals for the Fifth ...

With technology/AI taking over administrative and repetitive tasks, human roles will shift towards more strategic, creative, ...

Explore news and insights on climate change, environment policies, global warming and sustainable practices with The New York Times Climate and Environment section.

Now, a new study in the journal Environmental Science and Technology says it's possible that humans may be consuming anywhere from 39,000 to 52,000 microplastic particles a year.

Ocean pollution is widespread and getting worse, and when toxins in the oceans make landfall they imperil the health and well-being of more than 3 billion people, according to a new report by an ...

Biodegradable materials offer a possible way to reduce the environmental impact associated with single-use medical devices ...

Around the world, some 16 billion plastic syringes and 15 billion face masks are thrown away each year.1,2 Unknown in the first half of the 20th century, the global production, circulation, and ...

Bloomberg's ESG datasets give firms the information they need to make smarter decisions, anticipate risk with more confidence and reduce tedious work.

Agriculture and other human activities that require fossil fuels combustion since industrialisation started in the mid-1850s were the main drivers for the emissions.

According to its calculations, almost 48,000 marketing authorisations for medicines around the world would be at risk if the restrictions go through as currently planned, and that would mean that ...